L

Lumobiotics GmbH

2 employees

Lumobiotics develops light-controllable peptide drugs as safe cytolytic agents for treatment of solid cancers.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology

Photoswitchable drugs

Health Care

Infectious diseases

Peptides

Peptidomimetics

Therapeutics

Oncology

Drug development

Startup

Pharmaceuticals

Date founded

2017

FAQ